非共识投资被高估了吗?
Martín Casado 真正的观点是,忽视共识很危险,而不是共识投资本身很好。 经过10年、近200笔投资,他认为早期创投市场“相当高效”:独自判断可能意味着真正的洞察,但“也可能只是漏看了什么”。一家依赖后续融资的公司,最终必须变得可融资,无论它的第一位投资人当初有多么逆共识。
种子轮融资困难,不足以证明一家赢家当时真正属于非共识投资,几个轶事也无法终结争论。 Casado 质疑 Anduril 等案例,理由是其中涉及成就卓著的创始人、已知的市场信号或高价融资;一家暂时不受欢迎的公司,之后仍可能以高于市场的价格融资。正确的分析应当基于一篮子公司:比较那些快速完成上调轮、拿到大量投资意向书、定价高于中位数的公司的结果。
这场争论不只是寻找便宜货。 Casado 的生产性资产视角认为,投资人往往能识别好公司,并据此给出相应价格;但他也承认,人的认知可能影响结果。Torenberg 认为投资人不应靠价格套利获取回报,Leo Polovets 则引用 Peter Thiel 的规则:上调轮完成得越快、幅度越高,投资人越应该加大投入,因为这说明公司“正在起作用”。Polovets 还回忆称,他曾因认为一家公司的估值应为1000万美元而拒绝了2000万美元估值,结果眼看着它一路成长到100亿美元。
最高阿尔法的早期下注,往往从非共识开始,但在资本需求压垮公司之前,必须跨入共识。 Polovets 约10笔最佳投资中,有6-8笔花了数月才完成种子轮,之后种子轮到A轮或B轮的估值有时跳升20倍或50倍。在深科技领域,关键问题是:300万美元融资能否完成足够的里程碑,从而支持下一轮1000万美元融资;如果下一轮需要5000万-1亿美元,就等于假设公司能成为A轮融资排名前5%的项目。
稀缺资本会迫使公司节俭,而宽松资本可能制造脆弱性。 Casado 认为,融资困难会让公司提高现金效率。Torenberg 则反驳称,以完美执行为前提的快速估值上调可能搭出“纸牌屋”,而且大多数公司死于消化不良,而非饥饿。他认为,2021年那批拿到10亿美元级别B轮融资的公司,可能造成创投史上规模最大的资本损失之一,因为它们可以在不听取客户意见的情况下持续花钱。
只有当增长、防御性和单位经济性能穿越叙事,行业热潮才具有可投资性。 OpenAI、Anthropic 和 Cursor 已经带来了真实增长,最好的公司正在把过去需要5年的“3倍、3倍、2倍、2倍、2倍”路径压缩到1-2年;但一家做到1亿美元 ARR 的企业,如今也可能因更好的产品出现而跌回5000万美元。人形机器人、自动驾驶和国防则体现了另一种风险:巨大的 TAM 和战略兴趣,可能在独立经济模型尚未明确前就把价格推高。
更大的结果可能支撑更大的基金和更高的价格,但没有回报层面的数据,论点仍未得到证明。 Casado 提到,a16z 的投资组合中有 Stripe、Databricks、Coinbase 和 OpenAI 这几家接近1000亿美元规模的公司;Polovets 则反驳称,过去20年可能只有10-20家公司跨过这一规模。他们提出的检验方法很明确:判断赢家的定价是否高于所在阶段的中位数,以及创投利润是否主要来自这些高价公司,然后区分公司阿尔法与单纯的价格套利。
1. 对共识的认知不等于共识投资
Casado 最初的区分是:“做非共识投资很危险”,意思是忽视其他投资人的判断很危险,而不是跟随他们就是明智之举。在10年内完成近200笔投资后,他认为早期市场“比人们意识到的高效得多”。
他的学术类比揭示了其中机制:一篇优秀的研究,如果作者忽视评审委员会将如何评价论文,仍可能无法发表。同样,一家依赖后续融资的初创公司,最终必须让下一轮出资人能够理解和接受它。
Polovets 同意“最终必须走向共识”,但他最强的几笔Pre-Seed和种子投资往往都始于共识之外。在获得验证点之前,这些业务看起来都很可疑;证据出现后,估值迅速上升,后续投资人仍有上行空间,但需要支付的倍数低得多。
2. 著名赢家不能证明逆共识轮次表现更好
Casado 反对将 Anduril 称为非共识,核心在于定义。Polovets 指出,Palmer Luckey 是一位曾以10亿美元级别退出的连续创业者,Trae 非常出色,而公司又处在 Elon 的国防科技案例所形成的市场阴影下。Casado 认为,把这样的交易称为非共识,反而暴露了创投行业的封闭;Torenberg 回忆其种子轮估值约为1亿美元,Polovets 则表示它的每一轮都很贵。
Torenberg 认为 Scale 属于非共识,因为 Alexander Wang 在种子轮时只有18岁。Casado 反驳称,Scale 所处的是一个已知市场,且背后有出色的投资人;Polovets 也同意,它几乎所有轮次都竞争激烈。这场交锋说明,“热门与否”或“竞争激烈与否”可能比“是否共识”更容易量化。
3. 热门轮次可能同时包含信息与反身性
讨论反对把价格简单视为便宜货信号。Casado 的生产性资产视角是,投资人很聪明,会为他们认为优秀的公司付费;但他也承认,另一种视角认为人的认知会影响结果。Torenberg 认为投资人不应靠价格套利获取回报;Polovets 则引用 Peter Thiel 的经验法则:上调轮来得越快、幅度越高,就越应该加大投资,因为“它正在起作用”(“it’s working”)。
Casado 建议检验:高幅度上调轮最强的外部相关因素,是否只是上一轮本来就很热门。Polovets 表示,如果确实如此,就说明市场是有效的。Casado 还追问,相比规模很小、已经热门的公司群体,规模大得多的非热门公司群体,最终是否会产生更多热门公司。
双方都反对用单个公司的故事下结论。有效的一篮子分析应当跟踪快速完成后续融资、拿到10份A轮意向书或融资价格高于中位数的公司;即使经营业务令人失望,Polovets 也见过投资人热情帮助公司保住强劲结果,这表明认知可以独立于生产性价值发挥作用。
4. 创始人必须卖出共识,但不能放弃产品阿尔法
Torenberg 表示,创始人的反应高度一致:他们知道自己往往必须在产品市场上保持非共识,才能创造阿尔法;但在融资时,又必须“看起来像共识”。由于通常18-24个月后就会迎来下一轮融资,庆祝自己被所有人拒绝,可能直接损害公司的下一次融资。
Casado 认为,稀缺性也有反向作用。融资困难的团队往往更节俭,而热门公司可能基于完美执行的假设持续支出;一旦增长放缓,融资会突然消失,按照充裕资本设计的经营模式也很难收缩。
Torenberg 认为,过多资本会让创始人听不见真实市场——也就是客户——的声音。他说:“大多数公司死于消化不良,而不是饥饿。”他怀疑,2021年那批拿到10亿美元级别B轮融资的公司,造成了创投史上规模最大的资本损失之一。
因此,市场整体上可能有效,但在两端都可能失灵。Casado 表示,传统基础设施公司如果早两年可能很有吸引力,如今却因为不属于AI的甜蜜点而几乎无法融资;Torenberg 则补充称,一些AI公司正在获得投机性资金,即便没有人理解它们的商业模式。
5. 阶段决定投资组合能承受多少逆共识
在 Polovets 约10笔最佳投资中,有6、7或8笔花了数月完成种子轮,并遭遇大量拒绝。其中一些失败,是因为怀疑者判断正确;但成功的公司后来在种子轮与A轮或B轮之间录得20倍或50倍的估值差距。关键在于从非共识转向共识,因为永远无法完成这一转变会非常困难。
在深科技领域,Polovets 并不要求公司在A轮前拿出可运行的资产。他关注的是,公司能否实现技术上可信的里程碑,以及这些成果能否足够打动下一位投资人;换言之,他会明确承保下一支接盘基金需要看到什么。
资本需求会改变下注逻辑:融资300万美元,完成足以支持下一轮1000万美元融资的里程碑,可能是可行的。但如果计划用这300万美元之后就要求拿到5000万-1亿美元的A轮融资,就要求这家初创公司迅速成为共识项目,并跻身融资排名前5%。
Casado 自己的公司曾走过所有阶段:2007年以1000万美元投后估值完成热门种子轮;2008年金融危机后失去融资能力;出现“生命迹象”后再次完成热门融资;最终在 ARR 不到1000万美元时,以12亿美元被收购。在最低谷时,公司距离破产可能只有1个月,最初的开关硬件业务方向“根本说不通”。
6. AI 的速度与深科技泡沫将估值拉向相反方向
Polovets 表示,AI 已经让从100万美元增长到1亿美元的“3倍、3倍、2倍、2倍、2倍”路径显得过时;领先公司如今1-2年就能走完这条路。但护城河感觉更弱了:一家公司可以做到1亿美元 ARR,也可能在更好的产品发布后跌回5000万美元。
Torenberg 指出,OpenAI、Anthropic 和 Cursor 的巨大增长,是混乱市场底层真实存在的信号。Polovets 的投资组合中只有约10%-15%是纯AI项目,因此仍不确定该如何在前所未有的增长与不确定的持续性之间取得平衡。
深科技提供了更清晰的价格周期案例。Polovets 曾在3-4年前重仓国防,随后暂停投资1年半或2年,因为乌克兰和以色列相关事态发展推动估值上涨2-4倍,但基本面并未改变;当时一家国防公司估值4000万美元,却要与一家估值1500万美元、实力出色的能源公司竞争资本。
生物科技也经历过多轮周期,人形机器人则是最受追捧的领域之一,估值在收入提供足够锚定之前就变得极端。Polovets 通常避开已经融资数亿美元的共识赛道,因为新进入者往往只能以接近于零的资源起步。
7. 单位经济性必须经得起巨大 TAM 叙事
Casado 认为,通过押注几支出色团队、期待它们最终被收购来布局人形机器人,是一种合理策略,但他本人无法据此承保。他要求公司最终能够独立实现规模化经营,并指出“和人类身体竞争是一件非常、非常困难的事”;而且向工厂纵向整合,会把初创公司变成一家受约束的制造企业。
Casado 描述了约5万亿美元人类劳动力市场带来的估值扭曲:面对这样的 TAM,几乎任何种子轮价格都能被合理化。他用冷聚变作反证:把它称为最大的市场,也无法把物理定律变成一位优秀软件创始人可以解决的工程问题。
自动驾驶进一步凸显了经济性检验。经过行业约1000亿美元的投入后,Casado 认为其单位经济性大致与 Uber 持平:对 Google 或 Tesla 可行,对独立初创公司却很难,除非通过被收购,或经营 Applied Intuition 这类“卖铲子”的业务。
相比之下,Casado 能理解 ElevenLabs 和 Midjourney 这类AI模型公司的逻辑,因为它们的单位经济性和快速增长都清晰可见。他反对的是,把这些已经得到验证的信号直接迁移到其他领域,而那些领域既没有证明经济性,也没有证明技术可行性。
8. 结果规模扩大改变基金机制,但不改变证据要求
Torenberg 认为,如今的退出结果可能大1-2个数量级,因此以A轮或B轮价格投资,也可能获得过去只有种子轮才能实现的回报。Casado 同意,进入定义行业的那家公司可能是“高阶比特”,但也认为更大的下注需要更大的基金,以及接触更多 LP 资本。Polovets 补充称,多元化投资组合仍然需要足够多的公司。
Casado 提到,a16z 的投资组合中有 Stripe、Databricks、Coinbase 和 OpenAI 这几家接近1000亿美元规模的公司;Polovets 则估计,过去20年可能只有10-20家公司达到这一规模。他还补充称,十角兽出现的频率可能约为10年前的10倍,但1000亿美元级别的结果仍然罕见。
SoftBank、Tiger、Coatue 和 Insight 都曾以大基金逻辑进行测试,但结果好坏参半。Casado 表示,高价格可能不是唯一解释,宏观周期以及这些机构与传统硅谷早期创投网络的距离,也可能发挥了作用。Thrive、Founders Fund 和 a16z 也随着机会集扩大而募集了更大的基金。
Polovets 提出两种可行调整:将基金规模扩大10倍、保持持股比例,让更大的退出以同样比例回报整个基金;或者以更低的持股比例进行更多投资,提高捕捉“年度 Stripe”的概率。但当单笔支票达到1亿美元时,真正的非共识投资在结构上就会变得困难。
一个完全共识化的市场,最终会把创投压缩成资本成本比较:接受2倍回报的 LP 可以击败要求5倍回报的 LP,而双方看不到任何不同的东西。Casado 看重创投的上行导向,以及它在创造性破坏中的作用;而最好的产品,即使已被成熟投资人识别出颠覆潜力,对客户而言仍然是非共识的。
经验检验应分成两部分:先比较赢家的融资价格与其阶段中位数,再计算已实现回报是否主要来自那些持续高价融资的公司。Polovets 支持这一检验,也同意投资人不应寻求价格套利;他最大的几次错过,部分正是因为在公司估值2000万美元、而他认为应为1000万美元时选择放弃,之后公司却成长到了100亿美元。
种子轮仍然是分层市场,并未被多阶段基金征服。Polovets 的投资组合中约有10-12家独角兽,其中可能只有四分之一到三分之一在种子轮时就拥有重要的A轮投资人;连续创业者和熟悉市场的创始人,可能拿到4000万或8000万美元估值,而不是2000万美元,但不那么显而易见的公司仍然主要属于种子基金的领地。
It's dangerous to do non-consensus investing. That's a dangerous idea. If you're alone in your view, you may just be missing something.
Eventually, you have to get to consensus. If you're dependent on capital markets, it's very hard to keep the company alive if nobody wants to fund it. Peter Thiel once had a line that was like, “The faster and higher the up round, the more you should invest,” because it's working. Most companies fail from indigestion, not starvation.
So, Martín, it looks like you've helped spark a little bit of an existential crisis on venture Twitter and in VC, and I thought we'd all come here to talk about it.
Great. Super excited to be here.
Why don't we recap, Martín, from your perspective? What were you saying in that tweet? What were you trying to say in that tweet? Then we can get into the great back-and-forth that you and Leo had and get into the conversation.
Let me paraphrase the tweet. The paraphrased version of the tweet is: it's dangerous to do non-consensus investing. That's a dangerous idea.
The impetus of the tweet—which, by the way, wasn't well thought out, as I think a lot of viral tweets happen to be—was that I've been an investor for 10 years. I've done almost 200 investments, either running the fund or being directly involved. It seems that being blinkered to how VCs view companies is actually quite dangerous because you're so dependent on follow-on capital.
It reminds me a lot of being an academic. I used to write a lot of papers, and you do all of this great research, but when you write the paper, if you don't actually think about how the program committee will view it, it won't get accepted. It felt very similar to that.
I want to be very clear: I did not say, and I would never say, that consensus investing is a good idea. I'm just saying that not being aware of consensus is a bad idea. I think the underlying belief is that early markets are actually pretty darn efficient, a lot more efficient than people realize. If you're alone in your view, you may just be missing something.
Leo, we're stoked to have you join us as a friend and fellow venture nerd. What was your reaction?
I actually agree with a lot of what Martín just said, which is that eventually you have to get to consensus, whether it's when you're investing or later. Otherwise, if you're dependent on capital markets, it's very hard to keep the company alive if nobody wants to fund it.
For me—and maybe we invest a tick earlier, more toward pre-seed and seed—a lot of my best investments have been on the non-consensus side. Not in terms of having some crazy-good insight that nobody else had and being brilliant, but more because these companies often struggled in the early days. Before there are proof points, it's not obvious that they'll be a good idea. Once they get good, the valuation skyrockets so fast that you can still get good multiples, but they're much lower than at early stages.
Yeah, I had a few quibbles with some of the names on that list. Some people put Anduril on it, and it certainly was a controversial investment, but Palmer Luckey was a second-time founder with a billion-dollar exit. Trae is phenomenal, and this is in the shadow of Elon, who shows that you can already create these defense-tech companies.
If that's our definition of non-consensus, it just shows how insular we are as a community. It's almost an indictment of us that we even make this list.
And wasn't the seed round at around $100 million or something? It was a very expensive—
Every round was super expensive.
I'm not sure an ex-unicorn founder would ever be non-consensus, really.
Yeah, it is interesting because there are also rounds that are maybe non-consensus at $10 million or something, but then become super-hot rounds at $50 million or $100 million and then become $10 billion or $100 billion companies.
Even if you invested at that consensus round, you 10x-ed, or could have 100x-ed. So it sort of gets at the idea of, “Hey, if it's a hot deal, that must mean it's not good.” No. Peter Thiel once had a line that was like, “The faster and higher the up round, the more you should invest,” because it's working.
I would love to do a correlation analysis. Actually, Leo and I had what I thought was a very interesting discussion about trying to figure out how you'd actually measure this and how you'd actually throw some data at it. We have an analyst working on it now. The data isn't ready yet.
I have a new one, actually, that I want to test with you, Leo, as a good thing to test. I'll bet the best correlate of a high up round, outside of the business, is the fact that the previous round was hot.
I think that's probably true. If that's the case, it would suggest that the market's actually pretty efficient, because it's almost inductive that the previous round knew that the next round was going to be hot.
Well, I guess so. I do agree with that. I think the question for me is: where is there more opportunity?
If the 5 hot companies keep having great rounds and then there are 10,000 not-hot companies, but 100 of them become hot over time, even though the odds of becoming hot are low, most of the hot companies end up coming from the not-hot batch, right?
Right. So the question comes down to: is it easier to spot the company nobody sees or get into the company that's obviously good?
Maybe even further than that, to what extent do even high-priced rounds underprice hot deals? Because if I'm right—if the view is correct that hot deals are hot because they're good companies, and that the market is actually very efficient, and that drives most of the returns—then the next obvious question is: if that's the case, then the market isn't that efficient because it underpriced the company, right?
If the majority of returns are in high-priced rounds and the market has underpriced the company, then that seems like a contradiction. But risk-adjusted, that's not necessarily true. It could still be priced right because there's still a chance it goes to zero.
So I guess my sense is that until we run the numbers, we're not going to quite know the answer. A lot of these theories prove out pretty anecdotally, and I think maybe that's the problem: there's kind of an anecdote for every theory.
Yeah, I think the basket analysis is probably the most interesting one, right? Not how did this one company do, but how did this portfolio of companies that raised really quick follow-on rounds or had 10 term sheets at the Series A end up doing over time?
There are even cases in my portfolio where a super-hot company from an investor standpoint had so many term sheets, but the business didn't work out at the level that you would expect. The outcome was still really good.
On some level, even independent of the productive asset, human opinion about it matters. So there are almost 2 ways you can slice this conversation. One of them is that the asset is what's productive and produces the value, right? And the market will determine whether that's valuable or not.
Right? So that's this productive-asset view, and that's the one I hold. I think that investors are actually very smart. I think they know which companies are good, and then they pay for those. That's my view. But that's a productive-asset view.
There's another view that's independent of whether the company is good or not. There are things that people think are good, and so you're almost playing to the human perception of the company, independent of the underlying business. I would say, again, anecdotally, until we run the numbers, we won't know, but that also seems to be a bit true.
Yeah, I think I've been in venture for 12 or 13 years now. I've definitely seen this in sectors where sectors fall in and out of favor. E-commerce was hot, then it was dead, and then Dollar Shave Club got acquired and it was hot again. E-commerce didn't change that much year to year—I think the fundamentals didn't change that much—but the valuations and the appetite for investing and maybe starting companies changed a lot year to year. So to me, that's an indicator that it's not just the fundamentals; there are all these other forces, as you mentioned.
One other part to your tweet, Martín, that I think was underappreciated was the risk to founders of being seen as non-consensus. Founders need to raise money, and they need to raise follow-on funding within 18 to 24 months, sometimes even sooner. So if everyone is passing on you, or people are bragging about how other investors don't want to do your deal, that's not going to be super helpful to you in your next round.
I actually think the most interesting aspect of the tweet was the sociological study that followed of how different people interpreted it. The tweet itself was pretty banal, right? It's just a nonstatement. It's almost tautological. But different constituencies viewed it very differently.
Relatively inexperienced investors used it as an opportunity to say, “Oh, Andreessen Horowitz consensus-invests,” which anybody who knows anything about our investments knows is just totally not true. Even in my own portfolio, many of the top deals I've done had nobody else in the deal. So that was one cohort. There was another cohort, like Leo and Keith, who have a lot of data and have had a lot of really interesting things to say. That ended up in a great discussion, and I think there's still a lot more to do there.
But most of the founders—and I got a bazillion DMs—were like, “You're totally right.” The founders clearly view or feel this tension: it's dangerous to be non-consensus because they have to cater to VCs, and they know it. They see the pattern-matching responses; they deal with this all the time. From a founder perspective, you almost have to be non-consensus to have alpha in the actual product market, but you have to look consensus when you're raising. I think that's probably right.
I think this is probably one area where I differ a bit. I think there are benefits to being non-consensus. From the company side, when money is hard to raise, you tend to be more frugal with it. If the next round is less certain, there's less of a “it could crumble at any moment” aspect, because when things are hot and you're raising subsequent rounds very quickly on the assumption that everything will go perfectly, if anything slows down, suddenly you can't raise any more capital.
If you're in the mentality of growing quickly and spending, I think that's pretty hard. On the flip side, if you're consensus, it tends to be that you're more cash-efficient and more frugal out of necessity.
I think the other side is that it depends on the form of consensus. Sometimes there's also much softer diligence. The worst form of consensus I've seen is, “Oh, Sequoia and Andreessen and Humba are in this round. Let me just do a 2x markup in 2 weeks because I want to be in the same company.” There's no diligence there. It's just, “This is hot; let me do it.”
Maybe you're overlooking whether it's actually a good business. Sequoia and Andreessen and Humba all make good investments and bad investments, so maybe this is one of the bad ones, and you're just marking it up because you want to be in the hot deal. That ends up not being good for anyone.
I think this is a tremendously important and good point. I tend to believe now that most companies fail from indigestion, not starvation: they just raise too much money too easily. They don't listen to the actual market, which is the customer base, and as a result, they have a bunch of bad practices and end up running out of money.
I think there's a lot to that. If you looked at the 2021 cohort, the companies that had these billion-dollar B's—if you remember that time, it was totally crazy—I’ll bet that's probably one of the biggest wipeouts of capital. So I definitely think consensus investing is very dangerous, and only leaning into this for a founder is definitely dangerous.
But I also think the flip side is true: if you're totally blinkered to it, I think your life is pretty tough. There's a broader question as to, of the companies that do win, how many of them are competitive rounds versus noncompetitive rounds, and what the duration is between them being noncompetitive rounds and then becoming competitive. What percentage are really able to do that?
One question I have is: Is the market getting more efficient over time? With a lot more investors, we should be getting smarter as an asset class about how to evaluate these companies, along with a lot more capital. Are we just getting better? And if so, what does that mean?
Well, I'd love to hear Leo's view on this.
It's something I've been thinking about for a while. My take would be that for non-consensus companies, it's getting more efficient because the more investors there are, the more likely you are to find at least 1 or 2 that like what you're doing.
I think for consensus companies, it's starting to get more inefficient. When you have 10 term sheets, you get 5x the market value of what the fair value should be. That's great for the founder and maybe makes it a little more of a house of cards if things go south at all.
It's also not necessarily great for investors, because you might have to pay 2x, 3x, or 4x the actual intrinsic value—or the likely future value—of a company in order to get in.
But that would actually be efficient, right? It's just that the price is approaching the return profile. From a market standpoint, that would be efficient. I mean, it sucks from an investor standpoint because prices go up.
Yeah, that's what I'm saying. For founders, it's getting hyper-efficient. Maybe there's such an imbalance for really hot companies that your price gets bid up way past where it should be. Similarly, for non-consensus companies, it's the opposite: there aren't enough investors, so your price is lower than it should be, perhaps.
For me, those 2 are kind of the opposite ends of the spectrum.
Yeah, this is a great question. I totally agree. We can all acknowledge that there's a failure mode where consensus gets bubbly and then companies raise too much capital and there's a bunch of wipeouts. That has always happened, and it will always happen. That's just part of the market.
I think we can also all agree that there are parts of the market where there's probably unnecessary pessimism. For example, right now during this AI craze, in my area of traditional infra, a lot of the traditional companies that 2 years ago would have been great can't even raise right now just because they're not in the sweet spot. I think that will always be an aspect of the market, too.
But in general, for the mean investment, I do feel like the market over time has gotten a lot more efficient. We can deploy more dollars with more regularity, and the price is converging on what will ultimately be a fair price. This is acknowledging both of these failure modes on either side.
Yeah. And we're seeing one right now. It's the reality. There are AI companies that clearly are raising speculative money where nobody even really understands the business model, and there are great companies that can't get invested. We're seeing this right now.
But I will still say the reality is that OpenAI has grown tremendously, Anthropic has grown tremendously, and Cursor has grown tremendously. So there are some underlying market signals to fuel the chaos.
Yeah. I think part of it is that if you ever look at vintage-year data for venture funds, it’s probably a good way to see how consensus and non-consensus do over time. When you look at the dot-com bubble years, I think the median fund was terrible. It was like, hey, everyone overpaid, and the companies weren’t worth that. Even though everything was hot, it didn’t do well, and a lot of the funds didn’t do well.
Then, if you look at the Airbnb and Uber, around-2010 era, it’s kind of the opposite. I think the top-quartile funds crushed it because the market was pessimistic, and if you were willing to invest and had a different opinion, you did really well. Now it’s probably somewhere in the middle.
Maybe I’ll just go through my own startup as a single anecdote to frame the conversation a little bit. I did my PhD at Stanford. I was a classic “take the research and do a startup” person. We had so many term sheets before we had any idea what we were doing. It was the hottest thing ever, and it was great.
We did a seed round. Andy Rachleff from Benchmark joined my board, and we raised what at the time would have been a super-high-priced seed round: $10 million post-money. This was in 2007. Then the market tanked in 2008, and we still didn’t know what we were doing. It was just a bunch of researchers, so we couldn’t raise any money at all. Sequoia very famously gave us a black eye, and we couldn’t raise.
As we started to come out of the recession, Andreessen Horowitz, NEA, Lightspeed, and a few others got very interested, and then we had a pretty hot round again. We raised at a price that was actually over the market price, even though the business wasn’t quite working. There were signs of life. Then we had an incredibly hot round because the company started working.
When we actually sold the company, it returned the fund. It was one of the highest acquisition multiples of revenue at the time in enterprise software. So you kind of ask the question: Was the initial flurry of interest warranted or not? It turns out we were probably a month from going bankrupt, we didn’t know what we were doing, and the company definitely wasn’t working. What we had pitched at that time didn’t make any sense. We were like, “We’re going to change switch hardware,” which didn’t make any sense.
There’s one view that the market was overexuberant and we were lucky. There’s another view that says the initial conditions were there to do it. I just feel like if you run the data, it seems like the companies that have good outcomes did have sufficient interest along the way, because there were enough signals to do it.
On my side, for a lot of the pre-seeds and seeds I’ve done, I went back and I think maybe 6 or 7 or 8 of my top 10 investments took months to raise a seed round. A lot of times there were a lot of passes. They were all down to the wire, but then they ended up doing better over time. I think that transition from non-consensus to consensus ended up being really important, because if you never transition, it’s really hard. If you’re always consensus, that’s great for you.
One thing I noticed that was interesting is that a lot of the companies that struggled obviously just go to zero because the business isn’t that great and people recognize it. But for the ones that did well, a lot of times the gap between the seed and Series A, or the Series A and Series B, was literally 20x or 50x. I think as an investor, you can still get good returns at the Series A or B in those companies, but it’s so different to invest at the seed, where there’s like a 1,000x, versus at the Series A at $1 billion, where maybe there’s still a 10x or 20x. It’s just very different.
So, I’ve got a question for you, Leo, because I think you play a bit of a different game than we do. If you have a seed, which is, let’s call it, non-consensus—and again, we’re using this very vague definition of consensus—but they’re having a tough time raising and you’re the only person putting money in, do you have a theory on how it will beat consensus? Or is your belief that the underlying productive asset is going to do very well and that, by definition, is consensus?
Do you see the question? So the question is: Is this just true belief in the underlying business? The ultimate sign of success is just that the business is really working. So are you betting that, for the next raise, the business will definitely be working, or do you have some other theory on what will attract investors?
I’d say it’s often the latter. I’d say that’s especially true these days because I’m investing more in deep-tech companies. At seed, it’s very rare to see an asset that’s going to be working by the Series A, because usually the asset is still going to be developed at the Series A or maybe the Series B.
What I’m looking for is that there’s maybe not enough here for somebody to write a $5 million, $10 million, or $20 million check, but the company has milestones that I think, if they hit them, would make it consensus enough to merit a check of that size. Then I’m basically trying to evaluate, okay, the company has these milestones—do I think it could hit them or not? And if it hits them, are they compelling enough? I think that’s the big investment wager.
Yeah, yeah. So in this case, you do think about what the follow-on thing is going to want to see. You’ve reached a conclusion for the current round that is non-consensus.
Yeah. And I would say the consensus piece is part of it. I definitely meet companies where they’re like, “We’re raising $3 million right now. It’ll help us do these milestones, and then we think we can raise $10 million.”
Then there are others where it’s like, “We’re raising $3 million now, we’re going to hit these milestones, and then we want to raise a $50 million to $100 million Series A.” That’s actually a much harder bet, because you’re saying you have to assume they’re going to be consensus by the time they raise their next round, and it’s going to be a top 5% Series A. That’s a hard bet to take.
For the companies where the capital needs are more modest, or they have a more tranche-based roadmap, I think it’s a little bit easier to predict, like, hey, would these milestones be enough to raise $10 million? A lot of times I don’t know if it’ll be enough to raise $100 million—probably not—but $10 million feels pretty feasible if you do the things you think you’re going to do with this $3 million.
Has your view on this shifted? Do you find this AI wave to be different from previous waves, or are they fairly similar?
I’m probably a bad person to ask. I actually haven’t invested much in AI because of the deep-tech angle. Maybe 10% to 15% of my companies are pure AI. Others obviously use it in some way, but that’s not the product, I’m sure.
Well, how about deep tech, then? I think that’s also pretty different from what we were all investing in 5 years ago.
Maybe on the AI side—and I’ll touch on deep tech next—I think AI is interesting to me because, on the one hand, I’ve never seen faster growth. People talked about the triple-triple-double-double-double thing for a while, of getting from $1 million to $100 million in 5 years, and that seems so antiquated now. The best companies are doing that in 1 or 2 years.
Yeah.
I think on the flip side, the endurance—how long those companies endure, last, and grow—feels like much more of a question mark. In the triple-triple-double-double-double era, if you hit $100 million in ARR and there was no one close to you, you’d probably just keep growing. Now it feels like you could hit $100 million and then drop to $50 million because someone else came out with a better product.
I think the growth is amazing, and the moats are weaker, so I think there’s a counterbalance there.
I agree. Yeah.
On the deep-tech side, I definitely see areas with a lot of hype from time to time. For example, we invested a lot in defense 3 or 4 years ago, and then we kept looking but basically paused for a year and a half or 2 years. After the Ukraine and Israel thing, prices just went up 2, 3, or 4 times, but the company fundamentals didn’t change.
Then it started being an opportunity-cost question: Should I invest in this defense company at $40 million when there’s this really great energy company at $15 million? I think defense was kind of like that.
I think biotech has had a lot of ups and downs. In robotics, humanoids are probably one of the most hyped areas, where the valuations just get crazy before there’s any revenue. I feel like I lost the thread in the original question, but—
I was honestly just wondering how you thought about this current wave. You did a great survey of the set of waves, and I actually agree.
I would say that, for consensus areas like humanoids, we end up not explicitly but implicitly avoiding them because once you have a few companies that have raised hundreds of millions, whether they end up being great outcomes or not, I think it’s pretty hard for someone to start something new with near-zero resources and a team.
Yeah. I think there are all sorts of types of investing, and they’re all pretty valid. One type of investing is: humanoids are clearly interesting, and big companies are clearly interested in them. So why don’t you back a bunch of good teams, and worst case, they get acquired? I think that’s totally legitimate, but that’s not how I think at all. For me, the company has to make sense as a standalone business at scale.
Things like humanoids are tough for that, just because the unit economics right now are so unknown. Competing with a human body is a very, very hard thing to do. Then, of course, you can say, “Okay, well, we’ll put it where human beings can’t go, like a car factory.” But then all of a sudden, you’re building a manufacturing company, so you verticalize heavily. The company has to look at whatever sector the robot is going into, and it’s more constrained. I don’t understand the competitive set, and so on.
From my standpoint, the idea that this is very buzzy and hot in the industry for big companies, and that it may have an M&A outcome—I don’t know how to invest that way. I just don’t know how to handicap that. The way that I tend to view these things is, for AI, for better or for worse, you have great unit economics.
Everybody knows that we always talk about OpenAI and Anthropic, but if you talk about ElevenLabs, for example, or Midjourney, these are famously model companies where the unit economics are great. They’re growing very quickly, and so I understand that. But I think there’s been this weird thing—and this happens a lot—where people take the example of these model companies and apply it to totally different spaces, where you don’t have the proof points or the economic case. That’s one thing I don’t know how to do.
Certainly, I don’t believe we should all just follow the common consensus around areas to invest in. But I do think that there’s going to be a pool of capital, and it’s going to want companies to look a certain way. If you don’t consider that when you’re investing, I think life will be a lot more difficult.
Yeah, I agree. I have an aside here on the humanoid stuff. What I’ve seen over the last 10 or 15 years is that, if the market is big enough, it really distorts VC investing. It used to be that you would look at a market and say, “Oh, it’s a $2 billion-a-year market. If there’s a 1% chance they could capture it, they’ll be worth this much.”
So true. So let me justify a seed price. If the market is $5 trillion of human labor or something, any price makes sense, right? But then I think that really distorts how much value there is. The most boneheaded partner meetings were: “Well, yes, it is cold fusion, but this is the largest market ever. So, on the off chance it works…” I’m like, “This isn’t engineering, man. These are the laws of physics. I’m not sure that a good software founder is going to bend the laws of physics.”
I totally agree. I also feel like—I don’t want to harp on this too much—but unit economics is so important. What is the story for autonomous vehicles, right? The story for autonomous vehicles is that even after the industry has put $100 billion into it—$100 billion—the unit economics are still, let’s call it, on par with Uber. Let’s just call it that, right?
Does that make sense for venture investment? It’s really, really hard to build a standalone business with those types of economics. Google can do it, sure, and Tesla can do it, sure, but can startup X do it? No. So you’re either playing for, “This is a great company that got acquired,” which a lot of that happened and people made good money, but again, that’s not saying that the startup itself is a great business. Or you’re building picks and shovels, like Applied Intuition, where you’re building software for this market.
But I do think that a lot of investment dollars follow these spaces where there really is no thesis on the ultimate unit economics. I think you’re exactly right. I just think that there’s this kind of market-TAM sloppiness that says, “Well, if the market is inflated, then the expected payout is high.”
Also infinite.
That’s also infinite. Exactly right, yeah.
When I look at my portfolio, I see both. Some of the winners—Pave and Scale—were non-consensus, non-competitive, unproven, but very talented founders. Then, on the more consensus, competitive side, there were Jack Altman and Casser [?].
Wait, how is Scale non-consensus?
At seed, Alexander Wang was 18.
It’s a totally known space. He’s phenomenal. The A was done by Vulp who's amazing. I just feel like this is a very narrow definition of non-consensus.
Sure. For nearly all of the rounds, it was competitive, so I can agree with that.
Dan Levine—I mean, come on. These are some of the best investors in the world.
But I just mean to say that I brought the example to say that Casser’s [?] round was almost an order of magnitude more expensive. I think what people have been late to really internalize, and what a16z was super early to internalize, was just that the outcomes are an order of magnitude bigger—maybe 2 orders of magnitude bigger. So you can get seed-like returns at an order of magnitude, or even 2 orders of magnitude, more expensive.
I mean, remember, YouTube and Instagram were considered very expensive acquisitions at just a few billion dollars. In a few years, we’re going to have more trillion-dollar companies. Once we truly internalize the outcome expansion—the order of magnitude—I think it makes sense to Leo’s earlier point that it would beg the question: okay, but can you have 1,000x returns at not just what we used to consider seed-like pricing, but maybe at Series A or maybe even Series B?
Well, this is a very interesting question because you actually do run into fund mechanics as an actual price modulator in this discussion, right? You’re exactly right. I’ll go back to my company. My company was acquired for $1.2 billion. We had, let’s call it, less than $10 million in ARR, right? So does that make any sense? No. A lot of people were like, “This is totally crazy. This makes no sense.”
Except when I left, the run rate 3 and a half years later was, let’s say, $600 million within VMware, which acquired the company. And then right now it’s, let’s call it, $2 billion. It was actually, at one point in time, I think it was 40% of the growth of VMware—the business unit that I ran that was part of the acquisition. So clearly, it made sense to VMware.
As a result, you should say all the check sizes should be high for the winners because the outcome was so good, and this actually returned a lot of money to a lot of investors. The problem with that is I just think that would mean fund sizes would be too large, and you’d have to unlock different pools of capital—which, by the way, did start to happen during the SoftBank, Tiger, and Coatue era.
You could argue that all of their theses were correct, right? SoftBank was actually right, and Tiger was right, and it was actually a macro issue that caused the pullback, and that’s going to come back again. I think that’s a very legitimate thesis. But I really feel the reason that prices don’t continue to go up is more just access to LP capital.
So, Leo, let me try to make this a bit more concrete. I think what Erik said is correct: the outcomes are so big that it suggests the prices we actually pay are too low. So the question is, why are the prices too low? I think the answer is that we just don’t have the dollars to place all of those bets, and a number of people have actually questioned exactly this.
Very famously, SoftBank questioned this, Tiger questioned this, and Insight questioned this. They raised these huge funds and deployed a lot of capital. Those experiments had very mixed success. But it’s not obvious to me that the reason they had mixed success is because the prices were too high.
There are a lot of reasons why those could not have worked, including macro cycles and also the fact that none of them were Silicon Valley insiders. None of them were traditional early-stage investors, et cetera. So there’s a very reasonable question: maybe someone should just go run the Tiger strategy again, but as a Silicon Valley insider.
Well, in some ways, there are the failure cases, to some degree, but in some ways—I mean, Thrive raised bigger funds, Founders Fund raised bigger funds, and we raised bigger funds. The winners have also been multistage and have raised bigger funds. It could just be that this is the market being efficient: the reason more money is going into this and the funds are getting larger is because the opportunity set is larger, and this is just the market working its way out.
But Leo, you're very quiet, and this is actually a pretty controversial statement. I want to make sure that—
Well, I'm not sure what you mean by “we should be paying more.” Do you mean that you think the current prices are still well below where they should be?
I'm riffing off of Erik's statement, which I thought was right: venture capital has been a top-returning asset class, and you can look at individual investments. If you just take the top 10th percentile of funds, they return so much money. So there is an argument that even with these high prices, they're still underpriced.
And to put it differently, Leo, a seed fund may say, “Oh, I'm not going to invest in something at $50 million post-money or $100 million post-money because I don't think there's 1,000x potential. I don't think Databricks is going to be a $100 billion company, or OpenAI is going to be a $100 billion company, or whatever it is.” But it turns out—what we used to think—
I'm comparing—not to say OpenAI is going to be a $100 billion company. Exactly. Yeah, exactly. I mean, a few years ago, and so—
It doesn't seem like we've truly internalized that this is the norm, that there are going to continuously be $100 billion outcomes, if not—
Or that the market just continues to grow and therefore necessitates larger fund sizes. I would say that probably the venture market was 1/100th the size 20 years ago.
Yeah, probably something like that. It's kind of wild to think about.
Yeah. We did think a few years ago that there'd be a great contraction in the asset class, that 2021 was a blip, and that it would sort of right-size back to where it used to be. It doesn't seem to be the case that it's going to 2010 levels. I'm not sure if you guys have the data on you, but when I talk to our team, when I talk to Thrive, it seems that people think, no, more capital is just going to keep entering. I think some of that's just because companies stay private longer, too, right?
Yeah.
But I think the actual number of $100 billion-plus companies in the last 20 years is pretty small. I don't know the exact number, but I bet it's 10 or 15, or maybe 20 or something. So you're really betting you can get the 1 every year or 2 that gets there. If you're, let's say, doing a Series A at a $1 billion post-money or something, right, and you want 100x, even ignoring dilution.
Well, you'd have to bet that there are more of them, that more of them are going to happen, and that there are also more ways of getting liquidity from them as well. Martín, you—
But that also kind of suggests, purely by the numbers, that the most important thing is just being in 1 of those. The most important thing is being in 1 of those, if you can, independent of price, and that's the high-order bit. So I think I generally agree, right? If you're in the best company of the year, I don't think ownership matters that much. I don't think the price matters that much if it's going to be the best company 10 years forward.
I guess, to your earlier point, where if venture funds had more money, they would do higher valuations, it sounds like you could do the higher valuation today, too, though, right? Because you could just be like, “Hey, if we just want to get in this one, we'll pay twice the price and get half the ownership or something,” right?
You also need a diversified portfolio. You need enough companies.
No, you need the fund size to run that strategy. This is why I think a lot of this comes back to fund size. Even in the Andreessen portfolio, I was just thinking off the top of my head, we have 4 companies at the $100 billion mark, right? There's Stripe, Databricks, Coinbase, and OpenAI, so they're not that rare. You guys have awesome coverage. I guess the question is, how many more could you name from the last 15 years? My guess is 10 or 15, probably not 100, right?
Yeah.
Yeah, $20 billion-plus—there are a lot. In enterprise software, it used to be an adage that nobody ever broke $20 billion or $10 billion. Palo Alto Networks was at $15 billion, and we were like, “This is crazy.” Now so many of them have broken it. Maybe with $100 billion, you're right, but in the world that I live in, the number of decacorns is probably an order of magnitude greater than it was 10 years ago. On the face of it, that would argue for an order of magnitude higher fund size if you want to play the strategy of being in the winner.
There are clearly multiple strategies, but if you want to—again, I don't know. For me, the key question, which I don't know the answer to and want to run the numbers, is: If you take a dollar of earnings for a venture capitalist, did that come from a company that raised at high prices or not? I would guess the answer is yes, just because the winners are so outsized.
I mean, there are multiple ways to play it, right? If the outcomes are 10x bigger, you can have a 10x bigger fund and basically run the same playbook, keep the same ownership, and a big outcome still returns the same amount of the fund. You can also make more investments with a fraction of the ownership, and then each investment may move the needle less, but you have a higher chance of hitting the Stripe of the year, the Uber of the year.
Totally. Yeah, yeah. That's—
Yeah. So I think there are definitely different models that could work here.
Yeah, that's a good point. Yeah. No, you're—
All right. I want to make a few related points here. One is, I remember someone quote-tweeted Martín's tweet and said, “This is a sign that the asset class is dead,” or something—the idea of a more efficient market. I think what that really means is that an individual firm is going to lose if it can't compete and win deals in an efficient market.
My second point is that I think a lot of venture capitalist identity is tied to being non-consensus, to being able to see things that others can't see, because it's hard to win against all these other, much bigger, much more well-funded players. For that reason, I want to use the terms “consensus” and “non-consensus” less, because they're so core to people's identity, and use terms like, “Either it's a hot round or it's not a hot round; it was a competitive round or it wasn't competitive.”
I think another way of framing that, which isn't perfect, is: Is the company working or is the company not working at the point of investment? Let me add some nuance to it. If something is working, then it's okay. It's like: What is the price, what is the potential return multiple, and how does it work with your threshold, etc.?
There are some things that are competitive and not working but have an incredible founder or people, whatever. It's early enough that people believe the vision, and so you're still paying that price based on what you think. Then there are lots of things that are not working or not obviously working. We've chosen to do fewer consumer things that are pre-traction. So it's basically: Do you want to invest in things that have traction or no traction? There are failure modes with both, but it's another way of framing this debate. I'm curious—feel free to quibble with my framing.
I think I saw the same quote tweet. I'm probably somewhere in between. I don't think venture is dead. I think it gets a lot more fun if it's purely consensus. The reason is, I think in a purely consensus world, it all just comes down to cost of capital, right? If my LPs want 5x and yours want 2x, you could pay 2.5x higher prices. The company isn't better; it's just, “Oh, your cost of capital is lower, so you're going to win all the time.”
But also, we all see the same value. Everyone sees the same value. It's just who wants the smallest return to win the business. That just feels less exciting to me.
Yeah.
I mean—
That's exactly right. I'm going to get a little bit philosophical on this, but the thing that's always bugged me about PE investing and public-market investing is that it just doesn't care about productivity, really. I mean, it does to some degree, but if you're in a large public company, like I was, you realize that the public markets really care about predictability over innovation, for sure.
I mean, so innovation is stifled so much. In fact, it kind of causes large companies to protect themselves through incumbency and monopolistic practices and everything else, just because they’re not allowed to be aggressive on growth, right? So I feel like it’s almost this negative force on progress and innovation. I don’t want to be too dramatic about it, but I just feel like if you draw a dollar at random that gets invested, I’ll bet 90 cents of that dollar goes into keeping incumbents alive and/or predictability, and not to growth.
And I’m a huge believer in creative destruction, man. I’m like, “Get them out of the way. Let’s invest in growth.” So I love the idea of venture as an asset class getting more efficient, and I love the idea of more money going into it because the entire thesis is to grow. You never invest on downside loss—I don’t; I mean, I’m sure you don’t—I never invest on downside loss. I don’t care, right? You only invest on upside.
So to me, more dollars going into venture is only a positive for humanity. Again, I don’t mean to sound too grandiose, but I do feel it’s just a net positive. Well, so maybe on that front, I think it’s a really interesting perspective. I feel like, more from a company perspective than an investor perspective, a lot of the most disruptive products were maybe non-consensus at the time.
Totally.
Right, where you start with no buttons on the iPhone, or you have Uber instead of a taxi—it’s a stranger driving. And those are the ones where, if you were like, “I’m going to build a taxi company, but it’s 20% more efficient,” it probably can be a big business, but not quite the same level of disruption and growth as when you take a big bet. You might have a very high chance you’re wrong, but if you’re right, you’re going to be in a really good position.
Yeah, and this is so critical. I’m glad you brought it out. I really believe the best companies themselves are non-consensus to customers. I just think that the investing market is different from that. They kind of understand that, and therefore, a comment on investors being consensus is very different from a product being consensus. Does that make sense?
Investor sentiment, I think, is actually much smarter than people think. The adage is that VCs are dumb: they just chase trends, and all of that is true. But the reality is, as a group, we have identified a cohort of companies that are quite disruptive, invested in them, and priced them. Those companies themselves tend to be quite non-consensus to the actual consumer or to the market.
I do want to build, Martín, on your point because I think it’s so interesting, just to comment on how not everyone’s incentives are totally aligned here, especially between what’s good for the individual and what’s good for the ecosystem. In the sense that, yeah, if you’re an individual VC, you don’t want more capital, or if you’re a founder, you don’t want more founders in your space. But, to your point, competition is what fuels incredible products. It’s the Darwinian process at its best. This is how we get bigger startup outcomes, a bigger startup ecosystem, more value, and incredible products for customers and users.
This is how we solve cancer, man. More money goes into venture capital, and we invest in companies, as opposed to investing in dying companies’ ability to retain their place.
100%. All of finance needs to change.
And I think VCs are trying to straddle LP incentives, founder incentives, their own incentives, and there is some overlap, and there’s magic there. But it’s also just about acknowledging that not every individual person is aligned, and that’s okay.
I also do still very much believe in the barbell: that there will be these big, massive funds that continue to win and invest in compound value, and also these smaller, focused, concentrated, expert boutiques who absolutely crush it. We all work together.
So, Leo, we’re going to run the numbers. I was trying to get it done by now, but there’s a lot to do. The numbers are fuzzy. I just want to walk through what we’re going to be looking at, and then maybe we’ll schedule another podcast once the numbers are out to actually discuss it.
One of the numbers we’re going to look at is: if you cohort companies into winners and non-winners, call it looking at whether, on average, for any given company, the rounds were priced above or below the median for other companies at a similar stage. This will say whether a company was relatively highly priced for winners or not.
The other one, which is even more difficult to determine, is: given actual returns, are the bulk of the returns from companies that were, on average, highly priced or not? I think these 2 numbers will give us a sense of whether the market is actually pretty smart about value and price. You should not look for price arbitrage if you’re looking for returns. Does that sound fair?
Yeah, I think that sounds fair. I definitely agree with the not-looking-for-price-arbitrage piece, because I will say, for me personally, my best investments have been ones that, on average, took a while to raise their seed round. A lot of people didn’t get it; they didn’t like it.
But on the flip side, some of the biggest misses are also the ones where it’s like, “Oh, we liked everything except the price.” We thought it should be at 10, and some big fund gave them a term sheet at 20, so we passed—and now it’s a $10 billion company. So maybe that was not a good pass.
Yeah. Leo, honestly, as we go through this conversation, it does strike me that I think a lot of this is honestly just that we have a bit different perspectives. I have to deploy a lot more money than you do, right? I’m a Series A investor who needs to basically cap out $30 million to $40 million in order to have a significant position. And so I may have to be a bit more concerned about this than you do at the early stage. I’m sure stage does color this conversation quite a bit.
Yeah, everything you’re saying is totally sensible to me. So I don’t think there’s any disagreement.
I think if every check you write has to be at least $100 million, I think it’s actually very hard to do non-consensus. Yeah.
Right. Because there aren’t a lot of companies that hit a stage where you’d invest $100 million but it’s still not clear whether it’s a good company or not. And I think the earlier you go—if it’s $30 million checks, $10 million, $5 million, $1 million—you get more and more of a category where you have the option and you could do either one, assuming you have access to the consensus opportunities.
Leo, I’m curious what you think of Romin's thesis that multi-stage has won seed, more or less, in the last 10 years. When you look at a lot of the big winners, they were done from multi-stage firms at seed. I’m curious, first, if you agree with that reading of history, and second, if you think that’s likely going forward. By definition, you probably don’t think it’s unlikely going forward.
Can I join you guys?
Yeah, exactly.
I actually thought this was an interview. Sorry, what’s the next part of the question?
Did multi-stage win seed, or win more seed deals than seed firms won? Obviously, there’s First Round, Susa Ventures, and lots of great seed firms. But when you look at the aggregate of winners, did they have a multi-stage investor at seed or not? That’s RMT’s argument: they had a multi-stage investor at seed, and that’s why he co-invests with multi-stage firms as a whole strategy. And then the past isn’t necessarily the future. What do we think about the future?
I haven’t rigorously analyzed the $10 billion/$50 billion outcomes over the course of our history. I think we’ve invested in roughly 10 or 12 unicorns. Maybe a third or a quarter of those had a Series A investor at seed. I’m not really counting cases where sometimes the Series A investor did a $50,000 check in a Y Combinator round or something. I mean, they actually took half the round or more.
Most of them still were seed-only, or seed funds dominated the early round, and then they went to multi-stage very quickly after that. In my experience, I think there’s a subset of seed where I don’t know if I’d say multi-stage funds won, but they have a very strong advantage.
If it’s a founder who previously built a business that exited for $100 million and they’re in a space that they know super well, that’s going to get done at, say, 40 instead of 20, or 80 instead of 20 post-money. Chances are it’s going to be a multi-stage firm and not a boutique seed firm.
So I think for that segment, multi-stage hasn’t won, but the majority of the time they have a big leg up. For the other companies where it’s less obvious, it tends to be much more seed-dominated, or seed-fund-dominated.
Yeah, Martín, Leo, this has been a great conversation.